Sirolimus enhances the effect of apoptotic cell infusion on hematopoietic engraftment and tolerance induction

Leukemia

Volumn 22, Issue 7, 2008, Pages 1430-1434

  Bonnefoy, F ^a,b,c   Masson, E ^a,b,c   Perruche, S ^a,b,c   Marandin, A ^a,b,c   Borg, C ^a,b,c,d   Radlovic, A ^a,b,c   Shipman, B ^d   Tiberghien, P ^a,b,c   Saas, P ^a,b,c   Kleinclauss, F ^a,b,e  

^a INSERM   (France)

^b UNIVERSITÉ DE FRANCHE COMTÉ   (France)

^c ETABLISSEMENT FRANÇAIS DU SANG   (France)

^d UNIVERSITY HOSPITAL JEAN MINJOZ   (France)

^e HÔPITAL SAINT JACQUES   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN A; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; RAPAMYCIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; BONE MARROW TRANSPLANTATION; CONTROLLED STUDY; DRUG EFFICACY; ENGRAFTMENT; FLOW CYTOMETRY; GRAFT VERSUS HOST REACTION; HEMATOLOGIC MALIGNANCY; IMMUNOLOGICAL TOLERANCE; IMMUNOMODULATION; LETTER; MOUSE; NONHUMAN; OUTCOME ASSESSMENT; PRIORITY JOURNAL;

ANIMALS; APOPTOSIS; BONE MARROW CELLS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; IMMUNE TOLERANCE; IMMUNOSUPPRESSIVE AGENTS; MICE; MICE, INBRED BALB C; PHOTOPHERESIS; SIROLIMUS; T-LYMPHOCYTES, REGULATORY; TRANSPLANTATION CONDITIONING;

EID: 47549102268     PISSN: 08876924     EISSN: 14765551     Source Type: Journal    
DOI: 10.1038/sj.leu.2405061     Document Type: Letter

References (12)

1. Mohty M, Nagler A, Killmann NM. Reduced-intensity conditioning allogeneic stem cell transplantation: Hype, reality or time for a rethink? Leukemia 2006; 20: 1653-1654.
2. Maris M, Boeckh M, Storer B, Dawson M, White K, Keng M et al. Immunologic recovery after hematopoietic cell transplantation with nonmyeloablative conditioning. Exp Hematol 2003; 31: 941-952.
3. Maris MB, Niederwieser D, Sandmaier BM, Storer B, Stuart M, Maloney D et al. HLA-matched unrelated donor hematopoietic cell transplantation after nonmyeloablative conditioning for patients with hematologic malignancies. Blood 2003; 102: 2021-2030.
4. Morelli AE. The immune regulatory effect of apoptotic cells and exosomes on dendritic cells: Its impact on transplantation. Am J. Transplant 2006; 6 254-261.
5. Kleinclauss F, Perruche S, Masson E, de Carvalho Bittencourt M, Biichle S, Remy-Martin JP et al. Intravenous apoptotic spleen cell infusion induces a TGF-beta-dependent regulatory T-cell expansion. Cell Death Differ 2006; 13: 41-52.
6. Blaha P, Bigenzahn S, Koporc Z, Schmid M, Langer F, Selzer E et al The influence of immunosuppressive drugs on tolerance induction through bone marrow transplantation with costimulation blockade. Blood 2003; 101: 2886-2893.
7. Zeiser R, Nguyen VH, Beilhack A, Buess M, Schulz S, Baker J et al. Inhibition of CD4+CD25+ regulatory T-cell function by calcineurin-dependent interleukin-2 production. Blood 2006; 108 390-399.
8. Chen W, Jin W, Hardegen N, Lei KJ, Li L, Marinos N et al. Conversion of peripheral CD4+CD25- naive T cells to CD4+ CD25+ regulatory T cells by TGF-beta induction of transcription factor Foxp3. J Exp Med 2003; 198: 1875-1886.
9. Dvorak CC, Callard E, Agarwal R. Use of intravenous mycophenolate mofetil for graft-versus-host disease prophylaxis in an allogeneic hematopoietic stem cell transplant recipient with an allergic reaction to cyclosporin and tacrolimus. Bone Marrow Transplant 2006; 38 253-254.
10. Cutler C, Henry NL, Magee C, Li S, Kim HT, Alyea E et al. Sirolimus and thrombotic microangiopathy after allogeneic hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 2005; 11: 551-557.
11. Plumas J, Manches O, Chaperot L. Mechanisms of action of extracorporeal photochemotherapy in the control of GVHD: Involvement of dendritic cells. Leukemia 2003; 17: 2061-2062.
12. Maeda A, Schwarz A, Kernebeck K, Gross N, Aragane Y, Peritt D et al Intravenous infusion of syngeneic apoptotic cells by photopheresis induces antigen-specific regulatory T cells. J Immunol 2005; 174: 5968-5976.